In Utero Haematopoietic Stem Cell Transplantation (IUHSCT)
2009

In Utero Haematopoietic Stem Cell Transplantation

Sample size: 46 publication Evidence: moderate

Author Information

Author(s): Renda Maria Concetta Maggio, Aurelio Maggio

Primary Institution: Ospedali Riuniti 'Villa Sofia-Cervello', Palermo

Hypothesis

Can in utero haematopoietic stem cell transplantation (IUHSCT) effectively treat genetic disorders in fetuses?

Conclusion

The study suggests that while IUHSCT shows promise, achieving therapeutic levels of donor cell chimerism remains a significant challenge.

Supporting Evidence

  • Successful engraftment was only achieved in cases of X-SCID among the reported IUHSCT cases.
  • Animal models showed low levels of engraftment that were not therapeutic.
  • Strategies to improve donor cell competition and define immunological windows are necessary for better outcomes.

Takeaway

Doctors are trying to give sick babies healthy blood cells before they are born, but it's really hard to make it work.

Methodology

The study reviews cases of IUHSCT in humans and animal models, discussing barriers to engraftment and potential strategies to improve outcomes.

Limitations

The study highlights the limited success in achieving useful levels of chimerism in non-immunodeficiency diseases and the unclear reasons for failures.

Participant Demographics

The study includes 46 reported cases of IUHSCT in humans, primarily focusing on genetic disorders.

Digital Object Identifier (DOI)

10.4084/MJHID.2009.031

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication